BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 812348)

  • 1. Chemotherapy of Trypanosoma cruzi infections.
    Brener Z
    Adv Pharmacol Chemother; 1975; 13():1-81. PubMed ID: 812348
    [No Abstract]   [Full Text] [Related]  

  • 2. Chagas disease: pushing through the pipeline.
    Clayton J
    Nature; 2010 Jun; 465(7301):S12-5. PubMed ID: 20571548
    [No Abstract]   [Full Text] [Related]  

  • 3. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

  • 5. Parasitological cure of Chagas disease: is it possible? Is it relevant?
    Urbina JA
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 7. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious diseases. Drug developers finally take aim at a neglected disease.
    Leslie M
    Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific chemotherapy of Chagas disease: controversies and advances.
    Urbina JA; Docampo R
    Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of a novel compound, (e)-1-(4'-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene against Trypanosoma cruzi in mice.
    Barrett PA; Beveridge E; Bull D; Caldwell IC; Islip PJ; Neal RA; Woods NC
    Experientia; 1982 Mar; 38(3):338-9. PubMed ID: 6804255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi.
    Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG
    Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
    Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.
    Albareda MC; Natale MA; Cesar GL; Castro Eiro MD; Alvarez MG; Laucella SA
    Methods Mol Biol; 2019; 1955():339-348. PubMed ID: 30868539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can a killer be arrested?
    Kierszenbaum F
    Nat Med; 1996 Oct; 2(10):1071-2. PubMed ID: 8837597
    [No Abstract]   [Full Text] [Related]  

  • 16. Trypanocidal activity of Lychnophora staavioides Mart. (Vernonieae, Asteraceae).
    Takeara R; Albuquerque S; Lopes NP; Lopes JL
    Phytomedicine; 2003; 10(6-7):490-3. PubMed ID: 13678232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of ascorbic acid and cyanocobalamin in clearance of Trypanosoma cruzi.
    Ghobadifar MA; Kalani N; Gitiforouz M
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):401-2. PubMed ID: 24857404
    [No Abstract]   [Full Text] [Related]  

  • 18. The chemotherapy of chagas' disease: an overview.
    Paulino M; Iribarne F; Dubin M; Aguilera-Morales S; Tapia O; Stoppani AO
    Mini Rev Med Chem; 2005 May; 5(5):499-519. PubMed ID: 15892691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.
    Urbina JA; McKerrow JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7923-4. PubMed ID: 26578701
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.